Infiniplex provides hospitals and labs with patent-protected, qPCR-based blood tests for real-time tumor mutation monitoring. By leveraging ubiquitous qPCR technology, our solution offers a cost-effective, reliable approach to treatment monitoring, improving clinical decision-making and operational efficiency.